Background: Cognitive decline and fatigue are typical in multiple sclerosis (MS). However, there is no official medication for either of these symptoms.
Objective: The purpose of this study was to estimate the effects of a single dose of rivastigmine on processing speed and associated brain activity in patients with MS and subjective cognitive fatigue.
Methods: Fifteen patients with MS and subjective cognitive fatigue and 13 healthy controls (HCs) matched for age, gender and education performed a neuropsychological assessment and functional (f)MRI. A modified version of the Paced Visual Serial Addition Test (mPVSAT) was used as the behavioural task during fMRIs. After the first scanning session, both groups were randomly divided into two subgroups receiving either rivastigmine or placebo. A single dose of rivastigmine or placebo was administrated double-blindly and 2.5 hours later the scanning was repeated.
Results: At baseline, the patients with MS showed slower processing speed in mPVSAT compared with the HCs. They also demonstrated stronger bilateral frontal activation after sustained cognitive effort than the HCs. Performance improvement and a further activation increase in the left anterior frontal cortex and additional activation in the right cerebellum were observed in patients who received rivastigmine but not in patients on placebo, or in HCs with placebo or rivastigmine.
Conclusion: These preliminary findings suggest that rivastigmine may improve cognitive processing speed by enhancing compensatory brain activation in patients with MS.
RaoSMLeoGJBernardinLUnverzagtF. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology1991; 41: 685–691.
2.
DeLucaJCheluneGJTulskyDSLengenfelderJChiaravallotiND. Is speed of processing or working memory the primary information processing deficit in multiple sclerosis?J Clin Exp Neuropsychol2004; 26: 550–562.
3.
KruppLBElkinsLE. Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology2000; 55: 934–939.
4.
SchwidSRTylerCMScheidEAWeinsteinAGoodmanADMcDermottMP. Cognitive fatigue during a test requiring sustained attention: a pilot study. Mult Scler2003; 9: 503–508.
5.
KujalaPPortinRRevonsuoARuutiainenJ. Attention related performance in two cognitively different subgroups of patients with multiple sclerosis. J Neurol Neurosurg Psychiatry1995; 59: 77–82.
6.
RostiEHämäläinenPKoivistoKHokkanenL. The PASAT performance among patients with multiple sclerosis: analyses of responding patterns using different scoring methods. Mult Scler2006; 12: 586–593.
7.
ParmenterBADenneyDRLynchSG. The cognitive performance of patients with multiple sclerosis during periods of high and low fatigue. Mult Scler2003; 9: 111–118.
8.
CalabreseMRinaldiFGrossiPMattisiIBernardiVFavarettoA. Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing–remitting multiple sclerosis. Mult Scler2010; 16: 1220–1228.
9.
TartagliaMCNarayananSFrancisSJSantosACDe StefanoNLapierreY. The relationship between diffuse axonal damage and fatigue in multiple sclerosis. Arch Neurol2004; 61: 201–207.
10.
SepulcreJMasdeuJCGoñiJArrondoGVélez de MendizábalNBejaranoB. Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways. Mult Scler2009; 15: 337–344.
11.
StaffenWMairAZaunerHUnterrainerJNiederhoferHKutzelniggA. Cognitive function and fMRI in patients with multiple sclerosis: evidence for compensatory cortical activation during an attention task. Brain2002; 125: 1275–1282.
12.
AudoinBIbarrolaDRanjevaJPConfort-GounySMalikovaIAli-ChérifA. Compensatory cortical activation observed by fMRI during a cognitive task at the earliest stage of MS. Hum Brain Mapp2003; 20: 51–58.
13.
MaineroCCaramiaFPozzilliCPisaniAPestalozzaIBorrielloG. fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis. Neuroimage2004; 21: 858–867.
14.
AudoinBAu DuongMVRanjevaJPIbarrolaDMalikovaIConfort-GounyS. Magnetic resonance study of the influence of tissue damage and cortical reorganization on PASAT performance at the earliest stage of multiple sclerosis. Hum Brain Mapp2005; 24: 216–228.
15.
FornCBarros-LoscertalesAEscuderoJBellochVCamposSParcetMA. Cortical reorganization during PASAT task in MS patients with preserved working memory functions. Neuroimage2006; 31: 686–691.
16.
ChiaravallotiNHillaryFRickerJChristodoulouCKalninALiuWC. Cerebral activation patterns during working memory performance in multiple sclerosis using FMRI. J Clin Exp Neuropsychol2005; 27: 33–54.
17.
PrakashRSEricksonKISnookEMColcombeSJMotlRWKramerAF. Cortical recruitment during selective attention in multiple sclerosis: an fMRI investigation of individual differences. Neuropsychologia2008; 46: 2888–2895.
18.
HillaryFGGenovaHMChiaravallotiNDRypmaBDeLucaJ. Prefrontal modulation of working memory performance in brain injury and disease Review. Hum Brain Mapp2006; 27: 837–847.
19.
DeLucaJGenovaHMHillaryFGWylieG. Neural correlates of cognitive fatigue in multiple sclerosis using functional MRI. J Neurol Sci2008; 270: 28–39.
20.
RubergMVillageoisABonnetAMPillonBRiegerFAgidY. Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems. J Neurol Neurosurg Psychiatry1987; 50: 538–543.
21.
ChristodoulouCMacAllisterWSMcLinskeyNAKruppLB. Treatment of cognitive impairment in multiple sclerosis: is the use of acetylcholinesterase inhibitors a viable option?CNS Drugs2008; 22: 87–97.
22.
BaxterMGChibaAA. Cognitive functions of the basal forebrain. Curr Opin Neurobiol1999; 9(2): 178–183.
23.
ParryAMScottRBPalaceJSmithSMatthewsPM. Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine. Brain2003; 126: 2750–2760.
24.
CaderSPalaceJMatthewsPM. Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis. J Psychopharmacol2009; 23: 686–696.
25.
ShaygannejadVJanghorbaniMAshtariFZanjaniHAZakizadeN. Effects of rivastigmine on memory and cognition in multiple sclerosis. Can J Neurol Sci2008; 35: 476–481.
26.
GreeneYMTariotPNWishartHCoxCHoltCJSchwidS. A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments. J Clin Psychoparmacol2000; 20: 350–356.
27.
KruppLBChristodoulouCMelvillePScherlWFMacallisterWSElkinsLE. Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology2004; 63: 1579–1585.
28.
PolmanCHReingoldSCEdanGFilippiMHartungHPKapposL. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol2005; 58: 840–846.
29.
OldfieldRC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia1971; 9: 97–113.
30.
GoodkinDEHertsgaardDSeminaryJ. Upper extremity function in multiple sclerosis: improving assessment sensitivity with box-and-block and nine-hole peg tests. Arch Phys Med Rehabil1988; 69: 850–854.
31.
KurtzkeJF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology1983; 33: 1444–1452.
32.
RaoSM. Cognitive Function Study Group of the National MS Society. A Manual for the Brief Repeatable Battery of Neuropsychological Tests in MS. Milwaukee: Medical College of Wisconsin, 1990.
33.
RadloffLS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas1977; 1: 385–401.
34.
KruppLBLaRoccaNGMuir-NashJSteinbergAD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol1989; 46: 1121–1123.
35.
RombergARuutiainenJPuukkaPPoikkeusL. Fatigue in multiple sclerosis patients during inpatient rehabilitation. Disabil Rehabil2007; 1–6.
36.
FosLAGreveKWSouthMBMathiasCBenefieldH. Paced Visual Serial Addition Test: an alternative measure of information processing speed. Appl Neuropsychol2000; 7: 140–146.
37.
NagelsGD’hoogheMBKosDEngelborghsSDe DeynPP. Within-session practice effect on paced auditory serial addition test in multiple sclerosis. Mult Scler2008; 14: 106–111.
38.
NagelsGGeentjensLKosDVleugelsLD’hoogheMBVan AschP. Paced visual serial addition test in multiple sclerosis. Clin Neurol Neurosurg2005; 107: 218–222.
TalairachJTournouxP. Co-planar stereotaxic atlas of the human brain. New York: Thieme Medical Publishers, 1988, pp.84–110.
41.
FureyMLPietriniPHaxbyJVAlexanderGELeeHCVanMeterJ. Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory. Proc Natl Acad Sci USA1997; 94: 6512–6516.
42.
RomboutsSARBBarkhofFvan MeelCSScheltensP. Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer’s disease. J Neurol Neurosurg Psychiatry2002; 73: 665–667.
43.
StoodleyCJSchmahmannJD. Functional topography in the human cerebellum: a meta-analysis of neuroimaging studies Review. Neuroimage2009; 44: 489–501.
44.
PennerIKVogtARaselliC. The FSMC (Fatigue Scale for Motor and Cognitive Functions): a new patient reported outcome measure for cognitive and motor fatigue in multiple sclerosis. Mult Scler2005; 11: S66.
45.
KroenckeDCLynchSGDenneyDR. Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern. Mult Scler2000; 6: 131–136.
46.
BakshiRShaikhZAMiletichRSCzarneckiDDmochowskiJHenschelK. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler2000; 6: 181–185.
47.
PatrickEChristodoulouCKruppLB. New York State MS Consortium. Longitudinal correlates of fatigue in multiple sclerosis. Mult Scler2009; 15: 258–261.
